71 – 80 of 82
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.
- Contribution to journal › Article
- 2014
-
Mark
Primary Melanoma Tumors from CDKN2A Mutation Carriers do not Belong to a Distinct Molecular Subclass.
- Contribution to journal › Article
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
- Contribution to journal › Article
-
Mark
Inherited variation in the PARP1 gene and survival from melanoma
- Contribution to journal › Article
-
Mark
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
- Contribution to journal › Article
-
Mark
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
- Contribution to journal › Article
- 2013
-
Mark
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
- Contribution to journal › Article
-
Mark
Vemurafenib Synergizes with Nutlin-3 to Deplete Survivin and Suppresses Melanoma Viability and Tumor Growth
- Contribution to journal › Article
-
Mark
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
- Contribution to journal › Article
- 2012
-
Mark
Molecular profiling reveals low- and high-grade forms of primary melanoma
- Contribution to journal › Article
